Viewing Study NCT06420115



Ignite Creation Date: 2024-05-19 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06420115
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2024-04-26

Brief Title: Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects
Sponsor: University Hospital Padova
Organization: University Hospital Padova

Study Overview

Official Title: AOP2780 - Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TARGET
Brief Summary: Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer
Detailed Description: To assess whether a larger caliber 16G prostate biopsy needle increases the diagnostic capability of prostate neoplasia compared to a smaller caliber 18G needle while keeping perioperative complications constant

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None